Linita™

Linagliptin
DPP-4 Inhibitor (Antidiabetic Preparations)

Indication:

Management of type 2 diabetes mellitus.

Dosage & Administration:

The recommended dose of Linita^™ is one tablet once daily. No dosage adjustment is required in patients with type 2 diabetes having renal or hepatic impairment

Preparation:

Linita^™ Tablet: Box containing 30 tablets in blister pack.